Physician profile
Maxwell Bates Johnson
NPI 1568903888
$5,000.10
in general payments reported to CMS, 2019-2025
9 companies · $4,264 in 2025
The $4,264 reported for 2025 was more than what 91% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2021: $353 · 2023: $59.20 · 2024: $148 · 2025: $4,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,550 · Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,550.00 |
| Food and Beverage | $920.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $3,874.69 | 2025 | Integra, Omnigraft, Primatrix |
| Sientra, INC. | $352.90 | 2021 | |
| Urgo Medical North America, LLC | $153.33 | 2025 | Urgoclean Ag |
| Musculoskeletal Transplant Foundation INC. | $152.97 | 2019 | |
| Smith+Nephew, INC. | $147.50 | 2024 | Versajet |
| Acera Surgical, INC. | $131.15 | 2025 | Restrata Wound Matrix |
| Polynovo North America LLC | $104.83 | 2025 | Novosorb Btm |
| Inari Medical, INC. | $59.20 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Axogen | $23.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxwell Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.